Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
2.83
Nov 18 • 3:59 PM ET Dollar change+0.11 Percentage change(3.86%)
Aftermarket Close
2.87
Aftermarket • 7:59 PM ET Dollar change+0.04 Percentage change(1.59%)
Today, 5:05 AMRecursion reports FDA alignment on Phase 3 REC-4881 design for familial adenomatous polyposis, with adenoma excisions of at least 10 mm in the primary endpoint
Index
RUT
Market Cap
1.76B
Enterprise Value
1.28B
Income
-475.67M
Sales
68.23M
Book/sh
1.61
Cash/sh
0.89
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
600
IPO
Apr 16, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
25.81
P/B
1.75
P/C
3.16
P/FCF
-
EV/EBITDA
-
EV/Sales
18.75
Quick Ratio
5.01
Current Ratio
5.01
Debt/Eq
0.08
LT Debt/Eq
0.06
Option/Short
Yes / Yes
EPS (ttm)
-0.89
EPS next Y
-0.81
EPS next Q
-0.20
EPS this Y
38.90%
EPS next Y
7.67%
EPS next 5Y
19.33%
EPS past 3/5Y
-1.84% -22.39%
Sales past 3/5Y
23.30% 79.91%
EPS Y/Y TTM
50.69%
Sales Y/Y TTM
56.18%
EPS Q/Q
39.61%
Sales Q/Q
258.49%
Insider Own
10.15%
Insider Trans
-0.60%
Inst Own
59.25%
Inst Trans
3.06%
ROA
-36.29%
ROE
-48.72%
ROIC
-49.73%
Gross Margin
-39.97%
Oper. Margin
-725.44%
Profit Margin
-697.13%
SMA20
-21.60%
SMA50
-24.53%
SMA200
-18.26%
Trades
Shs Outstand
560.46M
Shs Float
560.07M
52W High
5.24 -46.09%
52W Low
2.50 13.00%
Volatility
9.55% 8.77%
ATR (14)
0.34
RSI (14)
35.91
Beta
1.25
Rel Volume
1.75
Avg Volume
23.58M
Volume
41,204,332
Perf Week
-21.31%
Perf Month
-22.81%
Perf Quarter
-15.42%
Perf Half Y
-4.56%
Perf YTD
-30.93%
Perf Year
-32.09%
Perf 3Y
-59.93%
Perf 5Y
-85.31%
Perf 10Y
-
Prev Close
2.72
Price
2.83
Change %
3.86%
Consensus
Buy
Avg. Price Target
$6.77
Implied Upside
+139.6%
Analysts8incl. previous ratings
Rating Distribution4 Buy · 4 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Dec 17, 2025Upgrade
JPM logoJJP Morgan
Neutral → Overweight$11+289.4%
Jul 03, 2025Resumed
MS logoMMorgan Stanley
Equal-Weight$5+77.0%
May 22, 2023Initiated
MS logoMMorgan Stanley
Equal-Weight$8+183.2%
Mar 16, 2023Initiated
NNeedham
Buy$17+501.8%
Sep 16, 2022Initiated
KEY logoKKeyBanc Capital Markets
Overweight$20+608.0%
Apr 18, 2022Downgrade
BAC logoBBofA Securities
Buy → Neutral$10+254.0%
Mar 04, 2022Downgrade
SSVB Leerink
Outperform → Mkt Perform$10+254.0%
Sep 21, 2021Initiated
BBerenberg
Buy$37+1,209.7%
May 11, 2021Initiated
SSVB Leerink
Outperform$33+1,068.1%
May 11, 2021Initiated
KEY logoKKeyBanc Capital Markets
Overweight$36+1,174.3%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Borgeson BlakeDirectorNov 03 '26Sale3.8840,000155,2006,068,287Nov 04 05:12 PM
Borgeson BlakeDirectorNov 03 '26Proposed Sale3.8840,000155,200Nov 03 11:24 AM
Borgeson BlakeDirectorOct 06 '26Sale4.8450,000242,0006,108,287Oct 07 06:08 PM
HERSHBERG ROBERTDirectorOct 06 '26Option Exercise2.2225,00055,500187,156Oct 07 06:08 PM
HERSHBERG ROBERTDirectorOct 06 '26Sale5.0025,000125,000162,156Oct 07 06:08 PM
Borgeson BlakeDirectorOct 06 '26Proposed Sale4.8450,000242,000Oct 06 11:48 AM
HERSHBERG ROBERTDirectorOct 06 '26Proposed Sale5.0025,000125,000Oct 06 11:09 AM
Khan NajatCEO and PresidentSep 08 '26Sale3.5222,40878,8222,072,890Sep 10 05:55 PM
Najat KhanOfficerSep 08 '26Proposed Sale3.5222,40878,822Sep 08 02:28 PM
Borgeson BlakeDirectorSep 01 '26Sale3.3430,000100,2006,158,287Sep 02 06:01 PM
Borgeson BlakeDirectorSep 01 '26Proposed Sale3.3430,000100,200Sep 01 04:21 PM
Gibson ChristopherFormer DirectorAug 21 '26Proposed Sale3.3977,290262,013Aug 21 11:27 AM
Gibson ChristopherFormer DirectorAug 20 '26Proposed Sale3.4075,000255,000Aug 20 11:32 AM
Gibson ChristopherFormer DirectorAug 19 '26Proposed Sale3.27100,000327,500Aug 19 11:54 AM
Gibson ChristopherFormer DirectorAug 18 '26Proposed Sale3.0026,80680,399Aug 18 05:14 PM
Gibson ChristopherFormer DirectorAug 13 '26Proposed Sale3.31100,000331,000Aug 13 12:58 PM
Gibson ChristopherFormer DirectorAug 12 '26Proposed Sale3.3750,000168,500Aug 12 11:56 AM
Gibson ChristopherFormer DirectorAug 10 '26Proposed Sale3.27100,000326,754Aug 10 04:59 PM
Gibson ChristopherFormer DirectorAug 07 '26Proposed Sale3.25100,000325,410Aug 07 12:42 PM
Borgeson BlakeDirectorAug 04 '26Sale3.2530,00097,5006,188,287Aug 06 05:09 PM
Borgeson BlakeDirectorAug 04 '26Proposed Sale3.2530,00097,500Aug 04 01:37 PM
Gibson ChristopherFormer DirectorAug 04 '26Proposed Sale3.2775,000244,875Aug 04 10:35 AM
Gibson ChristopherFormer DirectorJul 30 '26Proposed Sale3.0075,000225,000Jul 30 04:10 PM
Gibson ChristopherFormer DirectorJul 29 '26Proposed Sale3.0350,000151,372Jul 29 04:09 PM
Gibson ChristopherFormer DirectorJul 27 '26Proposed Sale3.0550,000152,703Jul 27 04:16 PM
Gibson ChristopherFormer DirectorJul 21 '26Proposed Sale3.04100,000304,263Jul 21 04:11 PM
Gibson ChristopherFormer DirectorJul 20 '26Proposed Sale2.90100,000289,766Jul 20 04:11 PM
Gibson ChristopherFormer DirectorJul 17 '26Proposed Sale2.97100,000296,726Jul 17 04:10 PM
Gibson ChristopherFormer DirectorJul 16 '26Proposed Sale3.11100,000311,065Jul 16 04:13 PM
Gibson ChristopherFormer DirectorJul 15 '26Proposed Sale3.33123,334410,283Jul 15 04:12 PM
Gibson ChristopherFormer DirectorJul 14 '26Proposed Sale3.30100,000330,473Jul 14 04:07 PM
Gibson ChristopherFormer DirectorJul 13 '26Proposed Sale3.43100,000343,048Jul 13 04:32 PM
Gibson ChristopherFormer DirectorJul 10 '26Proposed Sale3.54100,000353,577Jul 10 04:09 PM
Borgeson BlakeDirectorJul 07 '26Sale3.9640,000158,5006,218,287Jul 09 06:04 PM
Gibson ChristopherFormer DirectorJul 09 '26Proposed Sale3.80286,0001,085,716Jul 09 04:26 PM
Gibson ChristopherFormer DirectorJul 08 '26Proposed Sale3.69200,000737,694Jul 08 04:26 PM
Gibson ChristopherFormer DirectorJul 07 '26Proposed Sale3.95250,000987,500Jul 07 01:39 PM
Borgeson BlakeDirectorJul 07 '26Proposed Sale3.9640,000158,500Jul 07 11:36 AM
Gibson ChristopherFormer DirectorJul 06 '26Proposed Sale3.78100,000378,000Jul 06 03:28 PM
Gibson ChristopherFormer DirectorJul 02 '26Proposed Sale3.75100,000374,500Jul 02 12:54 PM
Gibson ChristopherFormer DirectorJul 01 '26Proposed Sale3.67100,000366,630Jul 01 05:19 PM
Bumpus NamandjeDirectorJun 18 '26Sale3.183,96312,602127,632Jun 22 04:32 PM
Gibson ChristopherDirectorJun 18 '26Proposed Sale3.20300,440962,341Jun 18 04:33 PM
Bumpus NamandjeDirectorJun 18 '26Proposed Sale3.183,96312,602Jun 18 09:44 AM
Gibson ChristopherDirectorJun 18 '26Proposed Sale3.1840,000127,200Jun 18 09:37 AM
Gibson ChristopherDirectorJun 05 '26Sale3.6240,000144,800883,735Jun 05 05:03 PM
Khan NajatCEO and PresidentJun 05 '26Sale3.5823,58884,4592,175,796Jun 05 05:02 PM
Najat KhanOfficerJun 05 '26Proposed Sale3.5823,58884,459Jun 05 01:29 PM
Gibson ChristopherDirectorJun 05 '26Proposed Sale3.6240,000144,800Jun 05 10:19 AM
Bumpus NamandjeDirectorJun 03 '26Sale3.544,38615,52643,171Jun 04 05:04 PM
Borgeson BlakeDirectorJun 02 '26Sale3.6830,000110,4006,169,863Jun 04 05:04 PM
Bumpus NamandjeDirectorJun 03 '26Proposed Sale3.544,38615,526Jun 03 10:16 AM
Borgeson BlakeDirectorJun 02 '26Proposed Sale3.6830,000110,400Jun 02 11:04 AM
Gibson ChristopherDirectorMay 22 '26Sale3.0840,000123,200883,735May 27 04:15 PM
Gibson ChristopherDirectorMay 22 '26Proposed Sale3.0840,000123,200May 22 10:13 AM
Gibson ChristopherDirectorMay 07 '26Sale3.3740,000134,800926,556May 08 04:59 PM
Borgeson BlakeDirectorMay 05 '26Sale3.5230,000105,6006,199,863May 07 04:44 PM
Gibson ChristopherDirectorMay 07 '26Proposed Sale3.3740,000134,800May 07 11:13 AM
Borgeson BlakeDirectorMay 05 '26Proposed Sale3.5230,000105,600May 05 10:22 AM
Gibson ChristopherDirectorApr 22 '26Sale3.6140,000144,400906,556Apr 24 04:23 PM
Gibson ChristopherDirectorApr 22 '26Proposed Sale3.6140,000144,400Apr 22 09:47 AM
Gibson ChristopherDirectorApr 07 '26Sale3.1040,000124,000906,556Apr 08 04:58 PM
Borgeson BlakeDirectorApr 07 '26Sale3.1030,00093,0006,229,863Apr 08 04:58 PM
Gibson ChristopherDirectorApr 07 '26Proposed Sale3.1040,000124,000Apr 07 10:46 AM
Borgeson BlakeDirectorApr 07 '26Proposed Sale3.1030,00093,000Apr 07 10:17 AM
Gibson ChristopherDirectorMar 23 '26Sale3.2540,000130,000906,556Mar 25 04:36 PM
Gibson ChristopherDirectorMar 23 '26Proposed Sale3.2540,000130,000Mar 23 10:49 AM
Taylor Ben RChief Financial OfficerMar 17 '26Sale3.397,95626,9711,180,318Mar 18 05:52 PM
Taylor Ben ROfficerMar 17 '26Proposed Sale3.397,95626,971Mar 17 10:53 AM
Khan NajatCEO and PresidentMar 09 '26Sale3.3528,29894,6602,262,085Mar 11 05:41 PM
Najat KhanOfficerMar 09 '26Proposed Sale3.3528,29894,662Mar 09 01:45 PM
Borgeson BlakeDirectorMar 03 '26Sale3.46170,000588,2006,259,863Mar 04 04:38 PM
Borgeson BlakeDirectorMar 03 '26Proposed Sale3.46170,000588,200Mar 03 12:45 PM
Gibson ChristopherDirectorFeb 19 '26Sale3.4640,000138,400906,556Feb 19 07:30 PM
Taylor Ben RChief Financial OfficerFeb 18 '26Sale3.0813,42641,3521,195,349Feb 19 07:30 PM
Gibson ChristopherDirectorFeb 19 '26Proposed Sale3.4640,000138,400Feb 19 10:27 AM
Taylor Ben ROfficerFeb 18 '26Proposed Sale3.0813,42641,352Feb 18 12:21 PM
Gibson ChristopherDirectorFeb 04 '26Sale4.1240,000164,800913,839Feb 06 05:53 PM
Borgeson BlakeDirectorFeb 03 '26Sale4.20220,000924,0006,429,863Feb 06 05:53 PM
Gibson ChristopherDirectorFeb 04 '26Proposed Sale4.1240,000164,800Feb 04 09:50 AM
Borgeson BlakeDirectorFeb 03 '26Proposed Sale4.20220,000924,000Feb 03 11:26 AM
Gibson ChristopherDirectorJan 20 '26Sale4.4740,000178,800913,839Jan 22 07:34 PM
Gibson ChristopherDirectorJan 20 '26Proposed Sale4.4740,000178,800Jan 20 11:26 AM
Borgeson BlakeDirectorJan 06 '26Sale4.36220,000959,2006,649,863Jan 08 05:01 PM
Gibson ChristopherDirectorJan 05 '26Sale4.2540,000170,000933,839Jan 07 05:04 PM
Borgeson BlakeDirectorJan 06 '26Proposed Sale4.36220,000959,200Jan 06 09:40 AM
Gibson ChristopherDirectorJan 05 '26Proposed Sale4.2540,000170,000Jan 05 11:07 AM
Taylor Ben RChief Financial OfficerDec 29 '25Sale4.1821,38389,381761,550Dec 30 07:35 PM
Khan NajatChief R&D Commercial OfficerDec 22 '25Sale4.41124,403548,592611,135Dec 29 05:24 PM
Taylor Ben ROfficerDec 29 '25Proposed Sale4.1821,38389,381Dec 29 09:41 AM
Najat KhanOfficerDec 22 '25Proposed Sale4.41124,403548,588Dec 22 12:20 PM
Gibson ChristopherChief Executive OfficerDec 19 '25Sale4.5040,000180,000913,839Dec 19 05:04 PM
Gibson ChristopherOfficerDec 19 '25Proposed Sale4.5040,000180,000Dec 19 09:52 AM
Gibson ChristopherChief Executive OfficerDec 04 '25Sale4.6340,000185,200933,839Dec 05 07:20 PM
Borgeson BlakeDirectorDec 02 '25Sale4.37220,000961,4006,869,863Dec 04 04:51 PM
Gibson ChristopherOfficerDec 04 '25Proposed Sale4.6340,000185,200Dec 04 10:01 AM
Borgeson BlakeDirectorDec 02 '25Proposed Sale4.37220,000961,400Dec 02 12:15 PM
Gibson ChristopherChief Executive OfficerNov 19 '25Sale4.1640,000166,400913,839Nov 19 07:37 PM
Gibson ChristopherOfficerNov 19 '25Proposed Sale4.1640,000166,400Nov 19 10:17 AM
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.
CEODr. Najat Khan Ph.D.
CFO & President of Recursion UKMr. Ben R. Taylor
Chief Technology OfficerMr. Benjamin Mabey M.S.
Chief Scientific OfficerDr. David Hallett Ph.D.
M.B.A.Mr. Nathan Hatfield J.D.